A clinical trial to compare two different doses of magnesium sulfate as an adjuvant to bupivacaine in transversus abdominis plane block for postoperative analgesia in caesarean section.
Phase 4
- Conditions
- Health Condition 1: 1- ObstetricsHealth Condition 2: O268- Other specified pregnancy relatedconditions
- Registration Number
- CTRI/2023/04/052058
- Lead Sponsor
- DrVijeta Bajpai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 18 - 35 years females belonging to the American Society of Anesthesiologists (ASA) Class I/II
2 Elective or Emergency LSCS under Subarachnoid block.
3 Normal bleeding profile.
4 No history of relevant drug allergy.
5 Patients willing to participate in the study.
Exclusion Criteria
1 Age <18 and >35 years.
2 Patient refusal.
3 Significant cardiovascular disease, hepatic dysfunction or renal dysfunction
4 Coagulation abnormalities and Bleeding disorder
5 Infection in the intended intervention site
6 Patient on intravenous MgSO4
7 Eclamptic or preeclamptic patient
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method